HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Doc’s Controversial Ideas About UV Benefits Could Gain Traction As Sunscreen Deterrents Add Up

Executive Summary

The American Academy of Dermatology has expressed concerns about possible declines in sunscreen use due to increased regulation and negative publicity. Across the pond, one dermatologist believes overemphasis of sun avoidance and sunscreen reliance actually could be a public health disservice.

You may also be interested in...



Octocrylene Now? Sunscreen Industry Under Growing Pressure As Environmental Concerns Mount

Lawmakers already are taking action to ban sales of oxybenzone- and octinoxate-containing sunscreens due to signals, however inconclusive, that the ingredients pose dangers to coral health. Now a new study suggests that octocrylene could be a concern as well.

NGO Sunscreen Reports Leave Consumers With Less-Than-Stellar Options

The Environmental Working Group's 2017 guide steers consumers toward mineral-based formulas due to purported risks associated with chemical actives, while Consumer Reports says mineral sunscreens are most likely to carry inflated SPF claims. Online chatter shows that consumers are understandably at a loss.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148459

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel